Grifols (GRFS) Operating Margin Growth (3y) (2013 - 2020)
Grifols (GRFS) Operating Margin Growth (3y) (2013 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 654.04 Bn | 633.28 Bn | 17.26 Bn | 120.00 |
| 2 | AbbVie | 470.61 Bn | 464.04 Bn | 12.70 Bn | 531.00 |
| 3 | Merck | 379.00 Bn | 371.86 Bn | 12.21 Bn | 3,082.00 |
| 4 | Novartis Ag | 303.30 Bn | 295.61 Bn | 11.24 Bn | 842.00 |
| 5 | Astrazeneca | 258.47 Bn | 253.57 Bn | 12.86 Bn | -95.00 |
| 6 | Amgen | 237.78 Bn | 223.79 Bn | 7.24 Bn | -347.00 |
| 7 | Gilead Sciences | 183.75 Bn | 180.57 Bn | 6.22 Bn | -15,844.00 |
| 8 | Pfizer | 160.91 Bn | 149.21 Bn | 10.94 Bn | 20,333.00 |
| 9 | Gsk | 106.07 Bn | 101.90 Bn | 8.24 Bn | -2,411.00 |
| 10 | Grifols | 5.48 Bn | 4.48 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 4,654.00 |
| Dec 31, 2019 | 4,716.00 |
| Mar 31, 2019 | 4,718.00 |
| Dec 31, 2018 | -6,078.00 |
| Jun 30, 2018 | 24.00 |
| Mar 31, 2018 | -211.00 |
| Dec 31, 2017 | -87.00 |
| Jun 30, 2017 | -2,507.00 |
| Mar 31, 2017 | -426.00 |
| Dec 31, 2016 | 2,319.00 |
| Sep 30, 2016 | -400.00 |
| Jun 30, 2016 | -474.00 |
| Mar 31, 2016 | -327.00 |
| Dec 31, 2015 | 6,755.00 |
| Sep 30, 2015 | -122.00 |
| Jun 30, 2015 | -220.00 |
| Mar 31, 2015 | 36.00 |
| Dec 31, 2014 | 939.00 |
| Sep 30, 2014 | 574.00 |
| Jun 30, 2014 | -3,434.00 |